We have been working with a team of experienced Clinical Pharmacists to bring you a new Medications Review Pathway. Developed to help you address your patients' medication needs, the new pathway is now directly accessible within your Vision 3 clinical system and Vision Anywhere application for quick and easy use.
Latest News
To assist in the implementation of GP Connect and support efficient 24 hour access to care for patients across England, Cegedim has recently launched a new version of its Appointments application.
Seasonal Influenza Clinical Audits - delivering quick and easy access to the essential information you need to carry out an effective flu campaign.
There have been some recent changes in the English QOF Indicators for 2020/21. AST003 has been removed and replaced by AST0007, this has resulted in the three Asthma Royal College of Physicians (RCP) questions no longer being counted towards achievement
During this busy flu season we want to ensure you are supported as much as possible. You will already be aware of our Seasonal Influenza Campaign Help Centre; which has been specifically developed to provide you with an evolving one stop area.
QAIF - Vision 3 is Ready for the 1st of October Releases – Wales only
Vision+ Reports - Supporting you with this year's flu campaign. In preparation for this year’s flu campaign we have created a suite of Vision+ Reports. These reports are now available and will help you:
Vision+ Reports - Supporting you with this year's flu campaign. In preparation for this year’s flu campaign we have created a suite of Vision+ Reports. We are also working to pull together a number of other resources to support you in delivering an effective flu campaign.
Coronavirus/Covid-19 Shielding Letter for Patients Working within a Local Lockdown Area – England only 6th August 2020 NHS Digital have provided us with an updated Shielded Patient letter for you to use for patients who were on the Shielded Patient List (SPL) and now find themselves working in an area affected by local lockdown. We have turned this into a Vision template letter
Clinical safety advisory blog post - availability of Lyumjev insulin products